The Chaperonin TRiC/CCT Inhibitor HSF1A Protects Cells from Intoxication with Pertussis Toxin

Jinfang Jia1, Manuel Zoeschg1, Holger Barth1

  • 1Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081 Ulm, Germany.

Toxins
|January 22, 2024
PubMed

Insights

The chaperonin TRiC/CCT inhibitor, HSF1A, protects cells from pertussis toxin (PT) by reducing its ADP-ribosylation activity. This study reveals a novel interaction and suggests HSF1A as a therapeutic strategy against whooping cough.

Area of Science:

  • Microbiology
  • Cellular Biology
  • Toxicology

Background:

  • Pertussis toxin (PT) from *Bordetella pertussis* causes whooping cough.
  • The chaperonin TRiC/CCT complex is crucial for protein folding and homeostasis.
  • TRiC/CCT is implicated in the activity of other bacterial toxins like *Clostridioides difficile* TcdB.

Purpose of the Study:

  • To investigate the protective effects of the TRiC/CCT inhibitor HSF1A against PT-induced cell intoxication.
  • To elucidate the mechanism by which HSF1A confers protection against PT.
  • To explore potential therapeutic applications of HSF1A for pertussis.

Main Methods:

  • Treatment of cells with PT and HSF1A.
  • Assay for ADP-ribosylated Gαi levels.
  • In vitro enzyme activity and cellular binding assays for PT.
  • Investigation of PTS1 interaction with CCT5.
  • Measurement of cAMP signaling pathways.

Main Results:

  • HSF1A significantly reduced ADP-ribosylated Gαi levels in PT-treated cells.
  • HSF1A did not affect PT's enzymatic activity or cellular binding.
  • A novel interaction between PTS1 and CCT5 was identified, with reduced signaling upon HSF1A treatment.
  • HSF1A mitigated PT-induced disruptions in cellular cAMP signaling.

Conclusions:

  • HSF1A demonstrates protective effects against pertussis toxin-induced cellular damage.
  • The findings suggest a novel mechanism involving TRiC/CCT and PTS1 in PT intoxication.
  • HSF1A represents a potential therapeutic lead for combating pertussis toxin pathogenicity.

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
18.0K
Cotranslational Protein Translocation01:20

Cotranslational Protein Translocation

Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
7.4K
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.2K